Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study.
about
Radiosensitizers in cervical cancer. Cisplatin and beyond.Pelvic irradiation modulates the pharmacokinetics of cisplatin in the plasma and lymphatic system.Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer.
P2860
Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study.
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@ast
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@en
type
label
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@ast
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@en
prefLabel
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@ast
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@en
P2093
P1476
Concurrent radiation, mitomyci ...... results of a phase I-II study.
@en
P2093
Rawlings G
Sturgeon J
P304
P407
P577
1984-09-01T00:00:00Z